Mike Constantino

9 Meters Biopharma, Inc. is a clinical-stage company pioneering novel therapies for people with rare or debilitating digestive diseases by studying unique GI biology.

The Wolfpack Investor Network (WIN) brings together the NC State entrepreneurial community, NC State alumni network, and innovative private companies to empower the businesses that drive our future. Our mission is to support the global NC State University entrepreneurial community with an angel investing platform that engages and leverages the power of the NC State University alumni network.

Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte’s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte’s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA’s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense. For more information, visit www.Humacyte.com.

9 Meters Biopharma, Inc. is a clinical-stage company pioneering novel therapies for people with rare or debilitating digestive diseases by studying unique GI biology.

The Wolfpack Investor Network (WIN) brings together the NC State entrepreneurial community, NC State alumni network, and innovative private companies to empower the businesses that drive our future. Our mission is to support the global NC State University entrepreneurial community with an angel investing platform that engages and leverages the power of the NC State University alumni network.

EY is building a better working world by creating new value for clients, people, society, the planet, while building trust in the capital markets. Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow. EY teams in more than 150 countries work across a full spectrum of services in assurance, consulting, tax, strategy and transactions, strengthened by sector experience and diverse ecosystem partners. Find out more about the EY global network: http://ey.com/en_gl/legal-statement